Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre

BJU International

Volumn 113, Issue SUPPL. 2, 2014, Pages 64-68

  Wilcox, Chloe B ^a   Gilbourd, Daniel ^a   Louie Johnsun, Mark ^a  

^a GOSFORD HOSPITAL   (Australia)

Author keywords

Active surveillance; Anxiety; Prostate cancer; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; AUSTRALIA; CANCER EPIDEMIOLOGY; CLINICAL ASSESSMENT TOOL; HEALTH SURVEY; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MEMORIAL ANXIETY SCALE FOR PROSTATE CANCER; MICTURITION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL FUNCTION; ACTIVE SURVEILLANCE; ATTITUDE TO HEALTH; CANCER CENTER; COITUS; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PENIS ERECTION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE;

ACTIVE SURVEILLANCE; ANXIETY; PROSTATE CANCER; QUALITY OF LIFE;

ANXIETY; AUSTRALIA; CANCER CARE FACILITIES; COITUS; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84905383709     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12557     Document Type: Article

References (25)

1. Penson DF, Rossignol M, Sartor AO, Scardino PT, Abenhaim LL. Prostate cancer: epidemiology and health-related quality of life. Urology 2008; 72 (Suppl.): S3-11
2. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 2011; 77: 588-91
3. Smith DP, King MT, Egger S et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ 2009; 339: b4817
4. Johansson E, Steineck G, Holmberg L et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 2011; 12: 891-9
5. Eggener SE, Mueller A, Berglund RK et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2013; 189 (Suppl. 1): S19-25
6. Dall'Era MA, Albertsen PC, Bangma C et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012; 62: 976-83
7. Lawrentschuk N, Klotz L. Active surveillance for low-risk prostate cancer: an update. Nat Rev Urol 2011; 8: 312-20
8. Abern MR, Aronson WJ, Terris MK et al. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database. Prostate 2013; 73: 409-17
9. Ischia JJ, Pang CY, Tay YK, Suen CF, Aw HC, Frydenberg M. Active surveillance for prostate cancer: an Australian experience. BJU Int 2012; 109 (Suppl. 3): 40-3
10. Klotz L. Active surveillance for favourable risk prostate cancer: what are the results, and How safe is it? Semin Radiat Oncol 2008; 18: 2-6
11. Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int 2012; 109: 1614-9
12. Vanagas G, Mickeviciene A, Ulys A. Does quality of life of prostate cancer patients differ by stage and treatment? Scand J Public Health 2013; 41: 58-64
13. Roth AJ, Rosenfeld B, Kornblith AB et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 2003; 97: 2910-8
14. Roth A, Nelson CJ, Rosenfeld B et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006; 47: 340-7
15. Dale W, Hemmerich J, Meltzer D. Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology 2007; 16: 493-8
16. van den Bergh RC, Essink-Bot ML, Roobol MJ, Schroder FH, Bangma CH, Steyerberg EW. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol 2010; 183: 1786-91
17. Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM. Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. J Clin Oncol 2009; 27: 1557-63
18. Burnet KL, Parker C, Dearnaley D, Brewin CR, Watson M. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 2007; 100: 540-3
19. Dale W, Bilir P, Han M, Meltzer D. The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer 2005; 104: 467-78
20. Thong MS, Mols F, Kil PJ, Korfage IJ, van de Poll-Franse LV. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int 2010; 105: 652-8
21. van den Bergh RC, Essink-Bot ML, Roobol MJ et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009; 115: 3868-78
22. Seiler D, Randazzo M, Leupold U et al. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners. Urology 2012; 80: 564-9
23. Latini DM, Hart SL, Knight SJ et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 2007; 178: 826-32
24. Bellardita L, Rancati T, Alvisi MF et al. Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance. Eur Urol 2013; 64: 30-6
25. Frydenberg M, Anderson J, Burney S, Ricciardelli L, Brooker J. Psychological stress associated with active surveillance for localised low risk prostate cancer. BJU Int 2013; 111 (Suppl. 1): 39